KOR

e-Article

PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 10 January 2024, 30(1):139-149)
Subject
Language
English
ISSN
15573265
10780432